Lauren B Shomaker1,2,3, Nichole R Kelly1,4, Rachel M Radin1,2, Omni L Cassidy1,2, Lisa M Shank1,2, Sheila M Brady1, Andrew P Demidowich1, Cara H Olsen5, Kong Y Chen6, Eric Stice7, Marian Tanofsky-Kraff1,2, Jack A Yanovski1. 1. Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD, USA. 2. Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD, USA. 3. Department of Human Development and Family Studies and Colorado School of Public Health, Colorado State University, Fort Collins, CO, USA. 4. Department of Counseling Psychology and Human Services, Prevention Science Institute, College of Education, University of Oregon, Eugene, CO, USA. 5. Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 6. Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD, USA. 7. Oregon Research Institute, Eugene, OR, USA.
Abstract
BACKGROUND: Depression is associated with poor insulin sensitivity. We evaluated the long-term effects of a cognitive behavioral therapy (CBT) program for prevention of depression on insulin sensitivity in adolescents at risk for type 2 diabetes (T2D) with depressive symptoms. METHODS:One-hundred nineteen adolescent females with overweight/obesity, T2D family history, and mild-to-moderate depressive symptoms were randomized to a 6-week CBT group (n = 61) or 6-week health education (HE) control group (n = 58). At baseline, posttreatment, and 1 year, depressive symptoms were assessed, and whole body insulin sensitivity (WBISI) was estimated from oral glucose tolerance tests. Dual energy X-ray absorptiometry assessed fat mass at baseline and 1 year. Primary outcomes were 1-year changes in depression and insulin sensitivity, adjusting for adiposity and other relevant covariates. Secondary outcomes were fasting and 2-hr insulin and glucose. We also evaluated the moderating effect of baseline depressive symptom severity. RESULTS:Depressive symptoms decreased in both groups (P < .001). Insulin sensitivity was stable in CBT and HE (ΔWBISI: .1 vs. .3) and did not differ between groups (P = .63). However, among girls with greater (moderate) baseline depressive symptoms (N = 78), those in CBT developed lower 2-hr insulin than those in HE (Δ-16 vs. 16 μIU/mL, P < .05). Additional metabolic benefits of CBT were seen for this subgroup in post hoc analyses of posttreatment to 1-year change. CONCLUSIONS:Adolescent females at risk for T2D decreased depressive symptoms and stabilized insulin sensitivity 1 year following brief CBT or HE. Further studies are required to determine if adolescents with moderate depression show metabolic benefits after CBT.
RCT Entities:
BACKGROUND:Depression is associated with poor insulin sensitivity. We evaluated the long-term effects of a cognitive behavioral therapy (CBT) program for prevention of depression on insulin sensitivity in adolescents at risk for type 2 diabetes (T2D) with depressive symptoms. METHODS: One-hundred nineteen adolescent females with overweight/obesity, T2D family history, and mild-to-moderate depressive symptoms were randomized to a 6-week CBT group (n = 61) or 6-week health education (HE) control group (n = 58). At baseline, posttreatment, and 1 year, depressive symptoms were assessed, and whole body insulin sensitivity (WBISI) was estimated from oral glucose tolerance tests. Dual energy X-ray absorptiometry assessed fat mass at baseline and 1 year. Primary outcomes were 1-year changes in depression and insulin sensitivity, adjusting for adiposity and other relevant covariates. Secondary outcomes were fasting and 2-hr insulin and glucose. We also evaluated the moderating effect of baseline depressive symptom severity. RESULTS:Depressive symptoms decreased in both groups (P < .001). Insulin sensitivity was stable in CBT and HE (ΔWBISI: .1 vs. .3) and did not differ between groups (P = .63). However, among girls with greater (moderate) baseline depressive symptoms (N = 78), those in CBT developed lower 2-hr insulin than those in HE (Δ-16 vs. 16 μIU/mL, P < .05). Additional metabolic benefits of CBT were seen for this subgroup in post hoc analyses of posttreatment to 1-year change. CONCLUSIONS: Adolescent females at risk for T2D decreased depressive symptoms and stabilized insulin sensitivity 1 year following brief CBT or HE. Further studies are required to determine if adolescents with moderate depression show metabolic benefits after CBT.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Lauren B Shomaker; Marian Tanofsky-Kraff; Deborah Young-Hyman; Joan C Han; Lisa B Yanoff; Sheila M Brady; Susan Z Yanovski; Jack A Yanovski Journal: Pediatr Diabetes Date: 2009-11-11 Impact factor: 4.866
Authors: Shakira F Suglia; Ryan T Demmer; Richa Wahi; Katherine M Keyes; Karestan C Koenen Journal: Am J Epidemiol Date: 2016-02-01 Impact factor: 4.897
Authors: Dana Dabelea; Elizabeth J Mayer-Davis; Sharon Saydah; Giuseppina Imperatore; Barbara Linder; Jasmin Divers; Ronny Bell; Angela Badaru; Jennifer W Talton; Tessa Crume; Angela D Liese; Anwar T Merchant; Jean M Lawrence; Kristi Reynolds; Lawrence Dolan; Lenna L Liu; Richard F Hamman Journal: JAMA Date: 2014-05-07 Impact factor: 56.272
Authors: Shelly K Annameier; Nichole R Kelly; Amber B Courville; Marian Tanofsky-Kraff; Jack A Yanovski; Lauren B Shomaker Journal: Appetite Date: 2018-01-31 Impact factor: 3.868
Authors: Lauren B Shomaker; Shelby Cox; Devon P Lehman; Nichole R Kelly; Katherine A Thompson; Rim M Mehari; Sheila M Brady; Ovidiu A Galescu; Andrew P Demidowich; Kong Y Chen; Marian Tanofsky-Kraff; Jack A Yanovski Journal: Psychol Health Med Date: 2019-11-04 Impact factor: 2.423
Authors: Lauren D Gulley; Lauren B Shomaker; Nichole R Kelly; Kong Y Chen; Eric Stice; Cara H Olsen; Marian Tanofsky-Kraff; Jack A Yanovski Journal: J Pediatr Psychol Date: 2019-11-01
Authors: Lauren D Gulley; Lauren B Shomaker; Nichole R Kelly; Kong Y Chen; Cara H Olsen; Marian Tanofsky-Kraff; Jack A Yanovski Journal: J Psychosom Res Date: 2022-03-10 Impact factor: 4.620
Authors: Lauren B Shomaker; Lauren Gulley; Allison M Hilkin; Emma Clark; Shelly Annameier; Sangeeta Rao; Bonny Rockette-Wagner; Andrea Kriska; Kenneth P Wright; Eric Stice; Kristen J Nadeau; Megan M Kelsey Journal: Contemp Clin Trials Date: 2018-10-17 Impact factor: 2.226
Authors: Armando Peña; Micah L Olson; Elva Hooker; Stephanie L Ayers; Felipe González Castro; Donald L Patrick; Libby Corral; Elvia Lish; William C Knowler; Gabriel Q Shaibi Journal: JAMA Netw Open Date: 2022-09-01
Authors: Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Roger Brown; Aleksandra E Zgierska; Shari Barlow; Supriya Hayer; Jodi H Barnet; Elisa R Torres; Christopher L Coe Journal: PLoS One Date: 2018-06-22 Impact factor: 3.240